In active response to the national healthcare reform initiative and to alleviate the medical burden on the public, with the aim of benefiting and serving…
Continue readingNotice: Drug Mark-ups Fully Abolished from July 1
JAMA Internal Medicine: TCM Jinlida Lowers the Risk of Developing Diabetes
On June 3, 2024, local time in the United States, the paper “Effect of Jinlida on Diabetes Prevention in Individuals with Impaired Glucose Tolerance and…
Continue reading


